Related Experiment Video

Updated: May 24, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance

Roel H Wilting1, Jan-Hermen Dannenberg

  • 1Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Division of Gene Regulation, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|February 24, 2012
PubMed

Insights

Cancer cells develop drug resistance through epigenetic changes, like DNA methylation and histone modifications. Epigenetic drugs offer a way to reverse this resistance, improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer drug resistance is a major clinical challenge, limiting the effectiveness of chemotherapy and targeted therapies.
  • Mechanisms of resistance include drug efflux, altered metabolism, target mutations, and pathway activation.
  • The reversible nature and rapid kinetics of acquired resistance suggest a significant epigenetic component.

Purpose of the Study:

  • To explore the role of epigenetic mechanisms in the development of cancer drug resistance.
  • To investigate how epigenetic modifications contribute to tumor cell heterogeneity and survival under drug pressure.
  • To highlight the potential of epigenetic drugs in overcoming or preventing anti-cancer drug insensitivity.

Main Methods:

  • Review of current literature on cancer epigenetics and drug resistance.
  • Analysis of genomic data linking epigenetic regulators to cancer progression and resistance.
  • Examination of the functional impact of epigenetic alterations on drug response pathways.

Main Results:

  • Epigenetic mechanisms, including histone modifications and DNA methylation, create transcriptional heterogeneity in tumors.
  • Aberrant epigenetic states can lead to the upregulation of drug transporters and DNA repair enzymes, conferring resistance.
  • Epigenetic regulators are implicated in driving cancer and acquiring drug resistance through further (epi)genetic changes.

Conclusions:

  • Epigenetic modifications play a crucial role in the dynamic development of cancer drug resistance.
  • Targeting reversible epigenetic changes with epigenetic drugs presents a promising strategy to overcome drug insensitivity.
  • Understanding these epigenetic mechanisms can lead to novel therapeutic approaches for cancer patients.

More Related Videos

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...